You are using an unsupported browser. Please use the latest version of Chrome, Firefox, Safari or Edge.

With world-class clinical services situated within the world’s top research hospital, we seamlessly connect:

  • Basic and applied neuroscience
  • Engineering and computer science
  • Genomics and molecular biology
  • Game-changing clinical innovation and compassionate patient care

These combined strengths position us to play a leadership role in tackling the great burden brain disorders pose to patients, their families and society.

Brain Mapping

Imagine a future where ...

  • Treatments for psychiatric illnesses, such as depression and schizophrenia, are personalized, timely and accessible.
  • Debilitating brain disorders are routinely prevented as part of a patient’s standard primary care experience.
  • Now-devastating diseases like Parkinson’s and Alzheimer’s are not only reversible, but preventable.
  • Loved ones who were previously paralyzed can once again move freely.

Mass General is ideally positioned to fulfill this vision thanks to our unequaled expertise and our deep scientific and clinical excellence, which extends from primary care to specialized services.

Psychedelic Research: A Partnership at the Forefront
Featured Story

Psychedelic Research: A Partnership at the Forefront

Thanks to funding from atai Life Sciences, Mass General has created the Neuroscience of Psychedelics atai Fellowship, where PhD students Grant Jones and Clare Shaffer exemplify how diverse and innovative work can emerge from a collaboration with a corporate supporter.

Read More

We’re investing in …

Doctor talking with patient
Close-up of circuits
residents listening to lecture